MX2015016603A - Composiciones de corticosteroides. - Google Patents

Composiciones de corticosteroides.

Info

Publication number
MX2015016603A
MX2015016603A MX2015016603A MX2015016603A MX2015016603A MX 2015016603 A MX2015016603 A MX 2015016603A MX 2015016603 A MX2015016603 A MX 2015016603A MX 2015016603 A MX2015016603 A MX 2015016603A MX 2015016603 A MX2015016603 A MX 2015016603A
Authority
MX
Mexico
Prior art keywords
corticosteroid compositions
compositions
corticosteroid
corticosteroids
manufacturing
Prior art date
Application number
MX2015016603A
Other languages
English (en)
Spanish (es)
Inventor
Robert Lathrop
David Wade Osborne
Original Assignee
Tolmar Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tolmar Inc filed Critical Tolmar Inc
Publication of MX2015016603A publication Critical patent/MX2015016603A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
MX2015016603A 2013-06-03 2014-06-02 Composiciones de corticosteroides. MX2015016603A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361830531P 2013-06-03 2013-06-03
PCT/US2014/040560 WO2014197398A1 (en) 2013-06-03 2014-06-02 Corticosteroid compositions

Publications (1)

Publication Number Publication Date
MX2015016603A true MX2015016603A (es) 2016-07-28

Family

ID=51014660

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015016603A MX2015016603A (es) 2013-06-03 2014-06-02 Composiciones de corticosteroides.

Country Status (10)

Country Link
US (2) US10111956B2 (enExample)
EP (1) EP3003272A1 (enExample)
JP (1) JP2016520656A (enExample)
CN (1) CN105263474A (enExample)
AR (1) AR096459A1 (enExample)
AU (1) AU2014275195A1 (enExample)
CA (1) CA2912873A1 (enExample)
HK (1) HK1223300A1 (enExample)
MX (1) MX2015016603A (enExample)
WO (1) WO2014197398A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9364485B2 (en) 2009-08-31 2016-06-14 Dr. Reddy's Laboratories Ltd. Topical formulations comprising a steroid
US20160184431A1 (en) 2014-03-11 2016-06-30 Promius Pharma Llc Topical compositions comprising a corticosteroid
ES2857602T3 (es) * 2014-03-11 2021-09-29 Promius Pharma Llc Composiciones tópicas de corticosteroides
ITUB20153490A1 (it) * 2015-09-08 2017-03-08 Novamont Spa Miscele di esteri dell?acido pelargonico
ITUB20153463A1 (it) 2015-09-08 2017-03-08 Novamont Spa Composizioni cosmetiche a base di polveri contenenti esteri dell?acido pelargonico
ITUB20153460A1 (it) * 2015-09-08 2017-03-08 Novamont Spa Composizioni cosmetiche acquose contenenti esteri dell?acido pelargonico
ITUB20153461A1 (it) 2015-09-08 2017-03-08 Novamont Spa Composizioni cosmetiche lipofile contenenti esteri dell?acido pelargonico
US20190008969A1 (en) * 2017-07-06 2019-01-10 Tioga Research, Inc. Compositions for drug delivery
UA128186C2 (uk) * 2017-11-27 2024-05-01 Умекрайн Когнішн Аб ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ 3<font face="Symbol">a</font>-ЕТИНІЛ-3<font face="Symbol">b</font>-ГІДРОКСІАНДРОСТАН-17-ОНУ ОКСИМУ
CN111904932B (zh) * 2019-05-08 2023-06-20 北京德立福瑞医药科技有限公司 一种含有糖皮质激素的胶束制剂及其制备方法
CN117881411A (zh) 2021-06-01 2024-04-12 艾迪雅生物有限责任公司 用于眼部药物的延长释放药物递送系统和使用方法
EP4344696A4 (en) * 2021-06-30 2025-07-09 D Nature Co Ltd FUNCTIONAL COMPOSITION FOR ALOPECIA COMPRISING AN EXTRACT DERIVED FROM CENTIPEDA MINIMA

Family Cites Families (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1048820A (en) * 1963-05-29 1966-11-23 Merck & Co Inc Emollient compositions containing liquid fatty acid esters
US4305936A (en) * 1980-10-09 1981-12-15 Dermik Laboratories Topical corticosteroid formulations
US4863738A (en) * 1987-11-23 1989-09-05 Alza Corporation Skin permeation enhancer compositions using glycerol monooleate
US5087620A (en) * 1990-05-17 1992-02-11 Bristol-Myers Squibb Co. Controlled dermal penetration enhancement using imidazoles
WO1994013257A1 (en) 1992-12-16 1994-06-23 Creative Products Resource Associates, Ltd. Occlusive/semi-occlusive lotion for treatment of a skin disease or disorder
JP3471840B2 (ja) * 1993-03-04 2003-12-02 日本ワイスレダリー株式会社 外用剤
US6113921A (en) 1993-03-23 2000-09-05 Pharmos Corp. Topical and transdermal delivery system utilizing submicron oil spheres
GB9311132D0 (en) 1993-05-28 1993-07-14 Eisai London Res Lab Ltd Control of cell death
US5989536A (en) 1993-07-03 1999-11-23 The Procter & Gamble Company Personal cleansing compositions containing alkoxylated ether and cationic ammonium salt for deposition of active agent upon the skin
EP0748203A1 (en) 1994-03-11 1996-12-18 The Procter & Gamble Company LOW pH, HYDROLYTICALLY STABLE, COSMETIC COMPOSITIONS CONTAINING ACIDIC ACTIVES
US6300326B1 (en) 1994-11-02 2001-10-09 Michael R. Dobbs Composition and method for control and treatment of cutaneous inflammation
AU4472396A (en) * 1994-12-30 1996-07-24 American Home Products Corporation Clear non-alcoholic hydrocortisone solutions
GB9504265D0 (en) 1995-03-03 1995-04-19 Medeva Plc Corticosteroid-containing pharmaceutical composition
US5948416A (en) 1995-06-29 1999-09-07 The Procter & Gamble Company Stable topical compositions
US6512010B1 (en) * 1996-07-15 2003-01-28 Alza Corporation Formulations for the administration of fluoxetine
GB9618964D0 (en) * 1996-09-11 1996-10-23 Tillotts Pharma Ag Oral composition
US5756014A (en) 1997-04-11 1998-05-26 Igen, Inc. Heat resistant lipid vesicles
US6066292A (en) 1997-12-19 2000-05-23 Bayer Corporation Sterilization process for pharmaceutical suspensions
US5972920A (en) 1998-02-12 1999-10-26 Dermalogix Partners, Inc. Formulation containing a carrier, active ingredient, and surfactant for treating skin disorders
EP1085913A1 (en) 1998-06-08 2001-03-28 Ferris Corporation Analgesic and antinociceptive methods
US6241969B1 (en) * 1998-06-26 2001-06-05 Elan Corporation Plc Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
ATE273682T1 (de) * 1999-06-25 2004-09-15 Durham Pharmaceuticals Ltd Topische formulierungen, die hautpenetrations- mittel enthalten, und ihre verwendung
US6723714B2 (en) 1999-07-06 2004-04-20 Blansett Pharmacal Co., Inc. Aqueous solvent for corticosteroids
JP2001233772A (ja) * 2000-02-23 2001-08-28 Taiho Yakuhin Kogyo Kk 外用剤組成物
KR100433614B1 (ko) * 2000-06-16 2004-05-31 주식회사 태평양 친수성 또는 염의 형태로 된 약물을 함유하는 경피흡수제제
US6843983B2 (en) 2001-06-07 2005-01-18 Virgie Bright-Ellington Shaving preparations and methods for the prevention and treatment of pseudofolliculitis barbae
US6765001B2 (en) 2001-12-21 2004-07-20 Medicis Pharmaceutical Corporation Compositions and methods for enhancing corticosteroid delivery
US20060140984A1 (en) 2002-10-25 2006-06-29 Foamix Ltd. Cosmetic and pharmaceutical foam
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US20070292359A1 (en) 2002-10-25 2007-12-20 Foamix Ltd. Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
US20080031907A1 (en) 2002-10-25 2008-02-07 Foamix Ltd. Cosmetic and pharmaceutical foam
US20070292461A1 (en) 2003-08-04 2007-12-20 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20080206161A1 (en) 2002-10-25 2008-08-28 Dov Tamarkin Quiescent foamable compositions, steroids, kits and uses thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US7981877B2 (en) 2003-01-23 2011-07-19 Patel Pravin M Stabilized steroid composition and method for its preparation
US7378405B2 (en) 2003-01-23 2008-05-27 Triax Pharmaceuticals, Llc Stabilized steroid composition and method for its preparation
US7186416B2 (en) 2003-05-28 2007-03-06 Stiefel Laboratories, Inc. Foamable pharmaceutical compositions and methods for treating a disorder
DE602004010130T2 (de) * 2003-07-07 2008-09-18 Nares Ab Mikroemulsionen und ihre verwendung zur prävention von erkrankungen der atemwege
US20060018852A1 (en) 2003-08-22 2006-01-26 L'oreal Compositions containing topical active agents and pentylene glycol
US20050043283A1 (en) 2003-08-22 2005-02-24 L'oreal S.A. Compositions containing topical active agents and pentylene glycol
JP2007533697A (ja) * 2004-04-22 2007-11-22 デュオコート エービー グルココルチコイド救急治療用の医薬組成物
AU2005313601B2 (en) * 2004-12-09 2012-05-24 Bayer Intellectual Property Gmbh Stabilisation of glucocorticoid esters with acids
US9314431B2 (en) 2005-02-14 2016-04-19 Transdermal Corp Solubilized benzoyl small molecule
US20060229364A1 (en) * 2005-03-10 2006-10-12 3M Innovative Properties Company Antiviral compositions and methods of use
US20070027152A1 (en) 2005-07-27 2007-02-01 Clark Kathleen L Topical anti-pruritic compositions and methods of action of same
FR2889662B1 (fr) * 2005-08-11 2011-01-14 Galderma Res & Dev Emulsion de type huile-dans-eau pour application topique en dermatologie
FR2898498B1 (fr) * 2006-03-15 2008-11-28 Galderma Sa Nouvelles compositions topiques sous forme d'emulsion h/e comprenant un glycol pro-penetrant
US7666859B2 (en) 2006-09-08 2010-02-23 Norman Turkowitz Skin compositions containing hydrocortisone
US20180353413A9 (en) 2006-09-08 2018-12-13 Norman Turkowitz Skin compositions containing hydrocortisone
GB2445539A (en) * 2006-12-29 2008-07-16 Ardana Bioscience Ltd Bigel composition
FR2911781B1 (fr) * 2007-01-26 2009-03-20 Fabre Pierre Dermo Cosmetique Emulsion dermatologique et procede de preparation
US20090088413A1 (en) 2007-09-27 2009-04-02 Burkenstock Sr Bruce Pharmaceutical composition for topical application
GB0720716D0 (en) 2007-10-23 2007-12-05 York Pharma Plc Novel formulation
US20090181068A1 (en) 2008-01-14 2009-07-16 Dunn Richard L Low Viscosity Liquid Polymeric Delivery System
US20090233892A1 (en) 2008-03-11 2009-09-17 Glenmark Generics Ltd Topical Compositions Comprising Hydrocortisone Butyrate
US20110308985A1 (en) 2009-02-26 2011-12-22 Gina Van Bogaert Composition of a liposomal gel containing hydrocortisone, its metabolites, precursors or mixtures thereof and the use thereof
EP2411014A2 (en) 2009-03-25 2012-02-01 Vanangamudi, Sulur Subramaniam A medicinal steroids cream and a process to make it
US20120270835A1 (en) 2009-04-13 2012-10-25 Apex Laboratories Private Limited Medicinal Cream Made Using Hydrocortisone Acetate and A Process To Make The Same
WO2010122452A1 (en) 2009-04-20 2010-10-28 Sulur Subramaniam Vanangamudi A medicinal antifungal and steroid cream incorporating a biopolymer and a process to make it
WO2010122453A1 (en) 2009-04-20 2010-10-28 Sulur Subramaniam Vanangamudi A medicinal cream containing miconazole nitrate, hydrocortisone acetate, and a biopolymer, and a process to make it
US20110269726A1 (en) 2010-04-30 2011-11-03 Valerie Goldburt Method of and system for treatment of inflammatory skin conditions
EP2579852B1 (en) * 2010-06-11 2014-12-31 Leo Pharma A/S A pharmaceutical spray composition comprising a vitamin d analogue and a corticosteroid
US8809307B2 (en) 2010-11-22 2014-08-19 Dow Pharmaceutical Sciences, Inc. Pharmaceutical formulations containing corticosteroids for topical administration
EP2709632A4 (en) 2011-05-16 2015-03-04 Dale L Pearlman COMPOSITIONS AND METHOD FOR THE TREATMENT OF SKIN DISEASES
US20140234227A1 (en) 2011-10-10 2014-08-21 Otic Pharma Ltd. Foam formulations
WO2013076160A1 (en) * 2011-11-21 2013-05-30 Université Libre de Bruxelles Sustained release formulations useful in the treatment of diseases
US8580286B2 (en) 2012-03-16 2013-11-12 Dale L. Pearlman Compositions and methods for the treatment of skin diseases
CN102940594A (zh) * 2012-12-04 2013-02-27 艾能赛克机械设备(江苏)有限公司 一种头发调理剂
KR101457789B1 (ko) * 2013-02-13 2014-11-03 동아제약 주식회사 상처 치료용 필름형성 약제학적 조성물 및 그의 제조방법
KR20150122719A (ko) 2013-02-28 2015-11-02 프리시전 더마톨로지, 인크. 증진된 생체이용률을 갖는 코르티코스테로이드의 국소 제제

Also Published As

Publication number Publication date
US20140357607A1 (en) 2014-12-04
US20190000977A1 (en) 2019-01-03
US20150209429A9 (en) 2015-07-30
EP3003272A1 (en) 2016-04-13
JP2016520656A (ja) 2016-07-14
AU2014275195A1 (en) 2015-12-10
WO2014197398A1 (en) 2014-12-11
AR096459A1 (es) 2015-12-30
CA2912873A1 (en) 2014-12-11
CN105263474A (zh) 2016-01-20
HK1223300A1 (zh) 2017-07-28
US10111956B2 (en) 2018-10-30

Similar Documents

Publication Publication Date Title
AU2015287674B2 (en) Topical antiviral compositions and methods of using the same
MX2020001756A (es) Compuestos deuterados del inhibidor vmat y el uso de dichos compuestos.
AU2016202480A1 (en) Seed-origin endophyte populations, compositions, and methods of use
MX2020005181A (es) Derivados de aminopiridina como inhibidores de cinasas de la familia de tyro3, axl y mer (tam).
PH12016501763A1 (en) Multispecific antibodies
TN2017000246A1 (en) Anti-c10orf54 antibodies and uses thereof
HK1223300A1 (zh) 皮质类固醇组合物
EP3102670A4 (en) Systems, methods, and compositions relating to combiomics
MX2016003843A (es) Inhibidores de cinasas asociadas al receptor de interleucina 1 (irak) y usos de los mismos.
EP3082819A4 (en) Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith
MX2021011906A (es) Composiciones de liberacion retardada de linaclotida.
MX2016008448A (es) Conjugados de var2csa-farmaco.
MX2020004205A (es) Composiciones antibioticas de ceftolozano.
EP3068500A4 (en) Fertilizer compositions and methods of making and using the same
MX2014005510A (es) Nuevas composiciones, produccion de las mismas y uso de las mismas para la produccion de poliamidas coladas.
AU2018253594A1 (en) Dihydroxyphenyl neurotransmitter compounds, compositions and methods
IN2013MU03641A (enExample)
PL2988764T3 (pl) Kompozycje przeciwłupieżowe i sposoby ich zastosowania
WO2014107596A8 (en) Compositions and methods for polynucleotide transfection
EP3071214A4 (en) Salacia compositions, methods of treatment by their administration, and methods of their preparation
EP3057596A4 (en) Compositions and methods of administering same
WO2014146111A3 (en) Analgesic compounds and methods of use
EP3089745A4 (en) Compounds, compositions, and methods for the treatment of cancers
IN2014DN06617A (enExample)
EP3057972A4 (en) Novel compositions, uses and methods for their preparation